{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T06:23:20Z","timestamp":1781850200893,"version":"3.54.5"},"reference-count":56,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":1461,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["kidney-international.theisn.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.kint.2015.10.001","type":"journal-article","created":{"date-parts":[[2016,1,4]],"date-time":"2016-01-04T06:52:39Z","timestamp":1451890359000},"page":"40-45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Targeting serum calcium in chronic kidney disease and end-stage renal disease: is\u00a0normal too high?"],"prefix":"10.1016","volume":"89","author":[{"given":"W. Charles","family":"O\u2019Neill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2015.10.001_bib1","first-page":"S77","article-title":"K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease","volume":"42","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2015.10.001_bib2","first-page":"S1","article-title":"KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)","volume":"113","year":"2009","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.kint.2015.10.001_bib3","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1681\/ASN.2007040449","article-title":"Pitfalls of measuring total blood calcium in patients with CKD","volume":"19","author":"Gauci","year":"2008","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2015.10.001_bib4","series-title":"Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory; Approved Guideline","first-page":"28","author":"Horowitz","year":"2010"},{"key":"10.1016\/j.kint.2015.10.001_bib5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF02556562","article-title":"Effect of menopause and aging on serum total and ionized calcium and protein concentrations","volume":"44","author":"Sokoll","year":"1989","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.kint.2015.10.001_bib6","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1681\/ASN.2007060673","article-title":"Postprandial mineral metabolism and secondary hyperparathyroidism in early CKD","volume":"19","author":"Isakova","year":"2008","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2015.10.001_bib7","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1172\/JCI107010","article-title":"Circadian rhythm in serum parathyroid hormone concentration in human subjects: correlation with serum calcium, phosphate, albumin, and growth hormone levels","volume":"51","author":"Jubiz","year":"1972","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2015.10.001_bib8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/sj.ki.5002009","article-title":"Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease","volume":"71","author":"Levin","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2015.10.001_bib9","doi-asserted-by":"crossref","first-page":"913","DOI":"10.2215\/CJN.06040710","article-title":"Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options","volume":"6","author":"Cunningham","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2015.10.001_bib10","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1172\/JCI118701","article-title":"Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in\u00a0vitro","volume":"97","author":"Slatopolsky","year":"1996","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2015.10.001_bib11","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1093\/ajcn\/47.6.1025","article-title":"Acute effects of oral phosphate-salt ingestion on serum phosphorus, serum ionized calcium, and parathyroid hormone in young adults","volume":"47","author":"Calvo","year":"1988","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.kint.2015.10.001_bib12","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1172\/JCI106432","article-title":"The role of phosphate in the secretion of parathyroid hormone in man","volume":"49","author":"Reiss","year":"1970","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2015.10.001_bib13","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/jbmr.5650010412","article-title":"The effect of oral phosphate administration on major indices of skeletal metabolism in normal subjects","volume":"1","author":"Silverberg","year":"1986","journal-title":"J\u00a0Bone Mineral Res"},{"key":"10.1016\/j.kint.2015.10.001_bib14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1172\/JCI112304","article-title":"Oral intake of phosphorus can determine the serum concentration of 1,25-dihydroxyvitamin D by determining its production rate in humans","volume":"77","author":"Portale","year":"1986","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2015.10.001_bib15","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1172\/JCI105493","article-title":"Studies of the mechanism by which phosphate infusion lowers serum calcium concentration","volume":"45","author":"Hebert","year":"1966","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2015.10.001_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM196601062740101","article-title":"Inorganic phosphate treatment of hypercalcemia of diverse etiologies","volume":"274","author":"Goldsmith","year":"1966","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2015.10.001_bib17","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1093\/oxfordjournals.ndt.a027665","article-title":"A\u00a0direct effect in\u00a0vitro of phosphate on PTH release from bovine parathyroid tissue slices but not from dispersed parathyroid cells","volume":"11","author":"Nielsen","year":"1996","journal-title":"Nephrol Dial Transpl"},{"key":"10.1016\/j.kint.2015.10.001_bib18","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/ki.1974.62","article-title":"Divalent ion metabolism in patients with acute renal failure: studies on the mechanism of hypocalcemia","volume":"5","author":"Massry","year":"1974","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2015.10.001_bib19","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJM198607173150304","article-title":"Calcium carbonate as a phosphate binder in patients with chronic renal failure undergoing dialysis","volume":"315","author":"Slatopolsky","year":"1986","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2015.10.001_bib20","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1172\/JCI111639","article-title":"Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxycholecalciferol in uremic patients","volume":"74","author":"Slatopolsky","year":"1984","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2015.10.001_bib21","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/ki.2012.403","article-title":"Oral calcium carbonate affects calcium but not phosphorus balance in stage 3\u20134 chronic kidney disease","volume":"83","author":"Hill","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2015.10.001_bib22","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/ki.2011.490","article-title":"Calcium balance in normal individuals and in patients with chronic kidney disease on low- and high-calcium diets","volume":"81","author":"Spiegel","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2015.10.001_bib23","doi-asserted-by":"crossref","first-page":"697","DOI":"10.2215\/CJN.00560206","article-title":"The case against calcium-based phosphate binders","volume":"1","author":"Moe","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2015.10.001_bib24","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJM200005183422003","article-title":"Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis","volume":"342","author":"Goodman","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2015.10.001_bib25","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1523-1755.2005.00185.x","article-title":"Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study","volume":"67","author":"Young","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2015.10.001_bib26","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis","volume":"15","author":"Block","year":"2004","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2015.10.001_bib27","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1053\/j.ajkd.2008.03.020","article-title":"Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"52","author":"Tentori","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2015.10.001_bib28","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1046\/j.1523-1755.2002.00434.x","article-title":"Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients","volume":"62","author":"Chertow","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2015.10.001_bib29","doi-asserted-by":"crossref","first-page":"104","DOI":"10.5414\/CNP62104","article-title":"Long-term comparison of a calcium-free phosphate binder and calcium-carbonate\u2014phosphorus metabolism and cardiovascular calcification","volume":"62","author":"Braun","year":"2004","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.kint.2015.10.001_bib30","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1111\/j.1523-1755.2005.00600.x","article-title":"Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis","volume":"68","author":"Block","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2015.10.001_bib31","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1093\/ndt\/gfh894","article-title":"Two year comparison of sevelamer and calcium carbonate effects on cardiovascular calcification and bone density","volume":"20","author":"Asmus","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2015.10.001_bib32","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/sj.ki.5002518","article-title":"The progression of coronary artery calcification in predialysis patients on calcium carbonate or sevelamer","volume":"72","author":"Russo","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2015.10.001_bib33","doi-asserted-by":"crossref","first-page":"c273","DOI":"10.1159\/000170783","article-title":"Phosphate binder impact on bone remodeling and coronary calcification\u2014results from the BRiC study","volume":"110","author":"Barreto","year":"2008","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.kint.2015.10.001_bib34","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1053\/j.ajkd.2008.02.298","article-title":"A\u00a01-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: The Calcium Acetate Renagel Evaluation-2 (CARE-2) study","volume":"51","author":"Qunibi","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2015.10.001_bib35","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1093\/ndt\/gfq725","article-title":"The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis","volume":"26","author":"Raggi","year":"2011","journal-title":"Nephrol Dial Transpl"},{"key":"10.1016\/j.kint.2015.10.001_bib36","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1681\/ASN.2012030223","article-title":"Effects of phosphate binders in moderate CKD","volume":"23","author":"Block","year":"2012","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2015.10.001_bib37","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2215\/CJN.03820411","article-title":"Mortality in kidney disease patients treated with phosphate binders: a randomized study","volume":"7","author":"Di Iorio","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2015.10.001_bib38","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1053\/j.ajkd.2010.10.055","article-title":"Effect of sevelamer and calcium-based phosphate binders on coronary artery calcification and accumulation of circulating advanced glycation end products in hemodialysis patients","volume":"57","author":"Kakuta","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2015.10.001_bib39","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1017\/S0007114514002785","article-title":"Acute and 3-month effects of microcrystalline hydroxyapatite, calcium citrate and calcium carbonate on serum calcium and markers of bone turnover: a randomised controlled trial in postmenopausal women","volume":"112","author":"Bristow","year":"2014","journal-title":"Br J Nutr"},{"key":"10.1016\/j.kint.2015.10.001_bib40","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/sj.ki.5002466","article-title":"Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients","volume":"72","author":"Suki","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2015.10.001_bib41","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/sj.ki.5002059","article-title":"Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients","volume":"71","author":"Block","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2015.10.001_bib42","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMoa1205624","article-title":"Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis","volume":"367","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2015.10.001_bib43","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1093\/ndt\/gfh125","article-title":"Determinants of progressive vascular calcification in haemodialysis patients","volume":"19","author":"Chertow","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2015.10.001_bib44","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1136\/bmj.39582.589433.BE","article-title":"Diagnosis and management of hypocalcaemia","volume":"336","author":"Cooper","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.kint.2015.10.001_bib45","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1093\/ndt\/gfn026","article-title":"Combined therapy with cinacalcet and low doses of vitamin D sterols in patients with moderate to severe secondary hyperparathyroidism","volume":"23","author":"Block","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2015.10.001_bib46","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1210\/jc.2012-1808","article-title":"Long-term follow-up of patients with hypoparathyroidism","volume":"97","author":"Mitchell","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.kint.2015.10.001_bib47","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.2215\/CJN.01520407","article-title":"Dynamics of parathyroid hormone secretion in health and secondary hyperparathyroidism","volume":"2","author":"Felsenfeld","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2015.10.001_bib48","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1046\/j.1523-1755.1999.00538.x","article-title":"Parathyroid function as a determinant of the response to calcitriol treatment in the hemodialysis patient","volume":"56","author":"Rodriguez","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2015.10.001_bib49","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1681\/ASN.V651371","article-title":"Differences in the dynamics of PTH secretion in hemodialysis patients with marked secondary hyperparathyroidism","volume":"6","author":"Felsenfeld","year":"1995","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2015.10.001_bib50","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1359\/JBMR.041221","article-title":"Decrease in thoracic vertebral bone attenuation with calcium-based phosphate binders in hemodialysis","volume":"20","author":"Raggi","year":"2005","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.kint.2015.10.001_bib51","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1681\/ASN.2006101089","article-title":"Effects of sevelamer hydrochloride and calcium carbonate on renal osteodystrophy in hemodialysis patients","volume":"19","author":"Ferreira","year":"2008","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2015.10.001_bib52","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1359\/jbmr.080803","article-title":"Dynamic and structural properties of the skeleton in hypoparathyroidism","volume":"23","author":"Rubin","year":"2008","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.kint.2015.10.001_bib53","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1093\/ndt\/gfp365","article-title":"Calcium balance in haemodialysis\u2014do not lower the dialysate calcium concentration too much","volume":"24","author":"Drueke","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2015.10.001_bib54","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1093\/ndt\/gfm765","article-title":"Calcium and potassium changes during haemodialysis alter ventricular repolarization duration: in\u00a0vivo and in silico analysis","volume":"23","author":"Severi","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2015.10.001_bib55","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/ndt\/gfn541","article-title":"Haemodynamic consequences of changing bicarbonate and calcium concentrations in haemodialysis fluids","volume":"24","author":"Gabutti","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2015.10.001_bib56","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1093\/ndt\/gfp700","article-title":"The diffusion gradient between the ionized calcium concentration in the dialysate and in the blood is the main driving force of the net calcium mass balance during haemodialysis","volume":"25","author":"Basile","year":"2010","journal-title":"Nephrol Dial Transplant"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815000022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815000022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T18:52:21Z","timestamp":1654023141000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815000022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S0085253815000022"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2015.10.001","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting serum calcium in chronic kidney disease and end-stage renal disease: is\u00a0normal too high?","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2015.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}